Late effect of Atomic bomb radiation on myeloid disorders: Leukemia and myelodysplastic syndromes

International Journal of Hematology

Volumn 95, Issue 3, 2012, Pages 232-238

  Tsushima, Hideki ^a   Miyazaki, Yasushi ^a   Iwanaga, Masako ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Atomic bomb survivors; Genomic instability; Ionizing radiation; Leukemia; Myelodysplastic syndromes

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; ATOMIC BOMB SURVIVOR; BLOOD SMEAR; BONE MARROW EXAMINATION; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DOSE RESPONSE; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; MYELODYSPLASTIC SYNDROME; RADIATION EXPOSURE;

DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LEUKEMIA, RADIATION-INDUCED; MALE; MYELODYSPLASTIC SYNDROMES; NUCLEAR WEAPONS; RADIATION INJURIES; SEX FACTORS; TIME FACTORS;

EID: 84863000417     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1002-4     Document Type: Article

References (11)

1. Fo1ley JH, Borges W, Yamasaki T. Incidence of leukemia in the atomic bomb survivors of Hiroshima and Nagasaki, Japan. Am J Med. 1952;13:311-21.
2. Ishimaru T, Hoshino T, Ichimaru M, Okada H, Tomiyasu T. Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 (October), pp. 1950-30, September 1966. Radiat Res. 1971;45(1): 216-33.
3. Ichimaru M, Ishimaru T, Belsky JH. Incidence of leukemia in Atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950-71. Radiation dose, years after exposure, age at exposure, and type of leukemia. J Radiat Res. 1978;19:262-82. (Pubitemid 9070651)
4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976;33:451-8.
5. Matsuo T, Tomonaga M, Bennett JM, Kuriyama K, Imanaka F, Kuramoto A, et al. Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia. Jpn J Clin Oncol. 1988;18:91-6.
6. Tomonaga M, Matsuo T, Carter RL, et al. Differential effects of atomic bomb irradiation in inducing major leukemia types: analyses of open-city cases including the Life Span Study cohort based upon update diagnostic systems and the dosimetry system 1986 (DS86). RERF TR 9-91. 1993.
7. Kamada N, Tanaka K, Oguma N, Mabuchi K. Cytogenetic and molecular changes in leukemia among atomic bomb survivors. J Radiat Res (Tokyo). 1991;32(Suppl 2):257-65.
8. Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic-bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res. 1994;137:S68-97. (Pubitemid 24060247)
9. Richardson D, Sugiyama H, Nishi N, Sakata R, Shimizu Y, Grant EJ, Soda M, Hsu WL, Suyama A, Kodama K, Kasagi F. Ionizing radiation and leukemia mortality among Japanese Atomic Bomb Survivors, 1950-2000. Radiat Res. 2009;172:368-82.
10. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-99. (Pubitemid 12073508)
11. Iwanaga M, Hsu WL, Soda M, Takasaki Y, Tawara M, Joh T, Amenomori T, Yamamura M, Yoshida Y, Koba T, Miyazaki Y, Matsuo T, Preston DL, Suyama A, Kodama K, Tomonaga M. Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors. J Clin Oncol. 2011;29:428-34.